The goal of this clinical research study is to learn if Altima (pemetrexed) can help to control urothelial cancer (bladder, urethra, and/or ureters) that has spread or cannot be controlled with surgery. The safety of this drug will also be studied. Researchers will also study how a gene called MTAP may affect the way the study drug works.